ArticleACS pharmacology & translational science2023

Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.

Mohammed Akhter Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.